Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 1, 2008, Pages 51-59

  Berlutti, F ^a   Superti, F ^b   Nicoletti, M ^c   Morea, C ^a   Frioni, A ^a   Ammendolia, M G ^b   Battistoni, A ^d   Valenti, Piera ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biofilm; Burkholderia cenocepacia; Cystic fibrosis; Lactoferrin

Indexed keywords

IRON; LACTOFERRIN;

ARTICLE; BACTERIAL STRAIN; BIOFILM; BURKHOLDERIA CENOCEPACIA; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 41849099253     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100107     Document Type: Article

References (26)

1. Berlutti F., M. Ajello, P. Bosso, C. Morea, A. Petrucca, G. Antonimi and P. Valenti. 2004. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 17:271.
2. Singh P.K., M.R. Parsek, E.P. Greenberg and M.J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417: 552.
3. Berlutti F., C. Morea, A. Battistoni, S. Sarli, P. Cipriani, F. Superti, M.G. Ammendolia and P. Valenti. 2005. Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int. J. Immunopathol. Pharmacol. 18: 661.
4. Stites S.W., B. Walters, A.R. O'Brien-Ladner, K. Bailey and L.J. Wesselius. 1998. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114:814.
5. Reid D.W., N.J. Withers, L. Francis, J.W. Wilson and T.C. Kotsimbos. 2002. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 121:48.
6. Singh P.K., A.L. Schaefer, M.R. Parsek, T.O. Moninger, M.J. Welsh and E.P. Greenberg. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762.
7. Middleton B., H.C. Rodgers, M. Camara, A.J. Knox, P. Williams and A. Hardman. 2002. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol. Lett. 207:1.
8. Petrucca A., P. Cipriani, P. Valenti, D. Santapaola, C. Cimmino, G.L. Scoarughi, I. Santino, S. Stefani, R. Sessa and M. Nicoletti. 2003. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res. Microbiol. 154:491.
9. Buhler T., S. Ballestero, M. Desai and M.R. Brown. 1998. Generation of a reproducible nutrient-depleted biofilm of Escherichia coli and Burkholderia cepacia. J. Appl. Microbiol. 85:457.
10. Boucher R.C. 2002. An overview of the pathogenesis of cystic fibrosis lung disease. Adv. Drug. Deliv. Rev. 54:1359.
11. Khan T.Z., J.S. Wagener, T. Bost, J. Martinez, F.J. Accurso and D.W. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075.
12. Machen T.E. 2006. Innate immune response in CF airway epithelia: hyperinflammatory? Am. J. Physiol. Cell. Physiol. 291:C218.
13. FitzSimmons S.C. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1.
14. Govan J.R. and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539.
15. Isles A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206.
16. Hoiby N., H. Krogh Johansen, C. Moser, Z. Song, O. Ciofu and A. Kharazmi. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3:23.
17. Sharon N. 2006. Carbohydrates as future antiadhesion drugs for infectious diseases. Biochim. Biophys. Acta 1760:527.
18. O'May C.Y., D.W. Reid and S.M. Kirov. 2006. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 48:373.
19. Ganz T. 2002. Antimicrobial polypeptides in host defense of the respiratory tract. J. Clin. Invest. 109: 693.
20. Valenti P. and G. Antonini. 2005. Lactoferrin: an important host defence against microbial and viral attack. Cell. Mol. Life Sci. 62:2576.
21. Burns J.L., M. Jonas, E.Y. Chi, D.K. Clark, A. Berger and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054.
22. Pier G.B., M. Grout, T.S. Zaidi, J.C. Olsen, L.G. Johnson, J.R. Yankaskas and J.B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64.
23. Schwab U., M. Leigh, C. Ribeiro, J. Yankaskas, K. Burns, P. Gilligan, P. Sokol and R. Boucher. 2002. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect. Immun. 70:4547.
24. Britigan B.E., M.B. Hayek, B.N. Doebbeling and R.B. Fick Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61:5049.
25. Rogan M.P., C.C. Taggart, C.M. Greene, P.G. Murphy, S.J. O'Neill and N.G. McElvaney. 2004. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J. Infect. Dis. 190:1245.
26. Berlutti F., S. Schippa, C. Morea, S. Sarli, B. Perfetto, G. Donnarumma and P. Valenti. 2006. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem. Cell. Biol. 84:351.